Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017;2017:3975417.
doi: 10.1155/2017/3975417. Epub 2017 Jun 27.

Body Posture, Postural Stability, and Metabolic Age in Patients With Parkinson's Disease

Affiliations
Free PMC article
Clinical Trial

Body Posture, Postural Stability, and Metabolic Age in Patients With Parkinson's Disease

Jacek Wilczyński et al. Biomed Res Int. .
Free PMC article

Abstract

Background: The study aims to analyze the relationship between body posture and composition, as well as postural stability in Parkinson's disease patients.

Material and methods: 32 people were evaluated. The study was conducted in the Laboratory of Posturology at Jan Kochanowski University in Kielce (Poland). Body posture was examined using the optoelectronic body posture Formetric Diers Method III 4D. Postural stability was evaluated using the Biodex Balance System platform. Body composition was assessed with the method of bioelectrical impedance analysis using the Tanita MC 780 MA analyzer.

Results: 11 patients (34.37%) had hyperkyphosis, 10 (31.25%) hyperlordosis, and 3 (9.37%) hyperkyphosis-hyperlordosis posture. Scoliosis (>10°) was observed in 28 (87.5%) subjects, whereas 4 (12.5%) presented scoliotic body posture (1-9°). In the examined population, all parameters of postural stability were within normal limits.

Conclusions: A significant positive correlation was observed between surface rotation (°), General Stability Index (r = 0.4075, p = 0.0206), and Anteroposterior Stability Index (r = 0.3819, p = 0.0310). There was also a significant positive correlation between surface rotation (+max) (°), General Stability Index (r = 0.3526, p = 0.0206), and Anteroposterior Stability Index (r = 0.3873, p = 0.0285). Metabolic age also presented a significant positive correlation between metabolic age and General Stability Index (r = 0.4057, p = 0.0212), as well as Anteroposterior Stability Index (r = 0.3507, p = 0.0490).

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Groiss S. J., Wojtecki L., Sudmeyer M., Schnitzler A. Deep brain stimulation in Parkinson-s disease. Therapeutic Advances in Neurological Disorders. 2009;2(6):379–391. doi: 10.1177/1756285609339382. - DOI - PMC - PubMed
    1. Elbaz A., Carcaillon L., Kab S., Moisan F. Epidemiology of Parkinson's disease. Revue Neurologique. 2016;172(1):14–26. doi: 10.1016/j.neurol.2015.09.012. - DOI - PubMed
    1. de Lau L. M., Breteler M. M. Epidemiology of Parkinson's disease. The Lancet Neurology. 2006;5(6):525–535. doi: 10.1016/S1474-4422(06)70471-9. - DOI - PubMed
    1. Adamiak U., Kaldonska M., Klodowska-Duda G., et al. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced parkinson disease. Clinical Neuropharmacology. 2010;33(3):135–141. doi: 10.1097/WNF.0b013e3181d47849. - DOI - PubMed
    1. Wirdefeldt K., Adami H., Cole P., Trichopoulos D., Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. European Journal of Epidemiology. 2011;26(1, supplement):S1–S58. doi: 10.1007/s10654-011-9581-6. - DOI - PubMed

Publication types

Feedback